MONASH researchers are trialling
beta-blockers as a potential way to
slow the spread of breast cancer.
Anaesthetist Dr Jonathan Hiller
is leading the clinical trials at the
Peter MacCallum Cancer Centre.
It builds on earlier findings
from the Monash Institute of
Pharmaceutical Science which
found chronic stress acts as a
fertiliser for tumour cells.
Hiller’s hypothesis is that betablockers,
which reduce blood
pressure by blocking the effect of
stress hormones, could potentially
help prevent the effects of acute
stress encountered in cancer
diagnosis and treatment.The above article was sent to subscribers in Pharmacy Daily's issue from 22 Feb 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 22 Feb 16
THE stark health inequalities between Australians living in regional and metro areas have been highlighted in a new report from The Royal Flying Doctor Service (RFDS).
AN “AI explosion” is sweeping Australia’s healthcare sector, signalling the arrival of an “extraordinary era of medicine”, according to a new report from CSIRO.
THE Australian and New Zealand College of Advanced Pharmacy (ANZCAP) has celebrated the 1,000th pharmacist to complete its pharmacy recognition program (PD 24 Nov 2023).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.